Personalized Medicine Market Size, Share, Growth Report 2032

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Personalized Medicine Market, 2024 - 2032 (USD Million)
  • 2.2. Global Personalized Medicine Market: Snapshot
•  
• Chapter 3. Personalized medicine Market - Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Global Personalized medicine market drivers: Impact analysis
    • 3.2.2. Increase in the disease incidence
    • 3.2.3. Highly effective, safe and fast results
  • 3.3. Market Restraints
    • 3.3.1. Global Personalized medicine market restraints: Impact analysis
    • 3.3.2. Complex nature of drugs
    • 3.3.3. High developmental cost
  • 3.4. Opportunities
    • 3.4.1. Favorable Government policies
    • 3.4.2. Recent developments create a suitable environment for drug development
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. The threat from new entrants
    • 3.5.4. The threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by Therapeutic area segment
    • 3.6.2. Market attractiveness analysis, by Application Segment
    • 3.6.3. Market attractiveness analysis, by Technology segment
    • 3.6.4. Market attractiveness analysis, by End-User segment
    • 3.6.5. Market attractiveness analysis, by regional segment
•  
• Chapter 4. Global Personalized medicine Market - Competitive Landscape
  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Personalized Medicine Market: company market share, 2024
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Launch
    • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
    • 4.2.4. R&D
    • 4.2.5. Regional Expansion
  • 4.3. Price Trend Analysis
  • 4.4. Technology Portfolio
•  
• Chapter 5. Global Personalized medicine Market - Therapeutic Area Segment Analysis
  • 5.1. Global Personalized Medicine Market: Therapeutic Area overview
    • 5.1.1. Global Personalized medicine market revenue share, by Therapeutic Area, 2024 and 2032
  • 5.2. Oncology
•  
• Chapter 6. Global Oncology Market, 2024 - 2032 (USD Million)
  • 6.1. Neurology
    • 6.1.1. Global Neurology Market, 2024 - 2032(USD Million)
  • 6.2. Cardiology
    • 6.2.1. Global Cardiology Market, 2024 - 2032(USD Million)
  • 6.3. Antiviral
    • 6.3.1. Global Antiviral Market, 2024 - 2032(USD Million)
  • 6.4. Psychiatry
    • 6.4.1. Global Psychiatry Market, 2024 - 2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Others market, 2024 - 2032 (USD Million)
•  
• Chapter 7. Global Personalized medicine Market - Application Segment Analysis
  • 7.1. Global Personalized medicine: Application overview
    • 7.1.1. Global Personalized medicine Market revenue share, by Application, 2024 and 2032
  • 7.2. Companion Diagnostics
    • 7.2.1. Global Companion Diagnostics Market, 2024 - 2032 (USD Million)
  • 7.3. Health Informatics
    • 7.3.1. Global Health Informatics Market,2024 - 2032(USD Million)
  • 7.4. Biomarker Identification
    • 7.4.1. Global Biomarker Identification Market, 2024 - 2032(USD Million)
  • 7.5. Clinical Research
    • 7.5.1. Global Clinical Research Market, 2024 - 2032(USD Million)
•  
• Chapter 8. Global Personalized medicine Market - Technology Segment Analysis
  • 8.1. Global Personalized medicine market: Technology overview
    • 8.1.1. Global Personalized medicine market revenue share, by Technology, 2024 and 2032
  • 8.2. Pharmacogenomics
    • 8.2.1. Global Pharmacogenomics Market, 2024 - 2032(USD Million)
  • 8.3. Metabolomics
    • 8.3.1. Global Metabolomics Market, 2024 - 2032(USD Million)
  • 8.4. Pharmacoproteomics
    • 8.4.1. Global Pharmacoproteomics Market, 2024 -2032(USD Million)
  • 8.5. Stem Cell Therapy
    • 8.5.1. Global Stem Cell Therapy Market, 2024 - 2032(USD Million)
  • 8.6. Pharmacodynamics
    • 8.6.1. Global Pharmacodynamics market, 2024 - 2032 (USD Million)
  • 8.7. Point of care
    • 8.7.1. Global Point of Care Market, 2024 - 2032 (USD Million)
  • 8.8. Pharmacokinetics
    • 8.8.1. Global Pharmacokinetics Market, 2024 - 2032 (USD Million)
•  
• Chapter 9. Global Personalized medicine Market - End-User Segment Analysis
  • 9.1. Global Personalized Medicine Market: End-User segment overview
    • 9.1.1. Global Personalized medicine Market revenue share, by End-User, 2024 and 2032
  • 9.2. Hospitals
    • 9.2.1. Global Hospitals Market, 2024 - 2032(USD Million)
  • 9.3. Molecular diagnostic laboratories and testing facilities
    • 9.3.1. Global Molecular diagnostic laboratories and testing facilities Market, 2024 - 2032(USD Million)
  • 9.4. Academic institutes, Clinical care, and research laboratories
    • 9.4.1. Global Academic institutes, Clinical care, and research laboratories Market, 2024 - 2032(USD Million)
  • 9.5. Contract Research organization
    • 9.5.1. Global contract research Organization Market, 2024 - 2032 (USD Million)
  • 9.6. Bio and health informatics companies
    • 9.6.1. Global Bio and health informatics companies Market, 2024 - 2032 (USD Million)
  • 9.7. Others
    • 9.7.1. Global Others Market, 2024 - 2032 (USD Million)
•  
• Chapter 10. Global Personalized medicine Market - Regional Segment Analysis
  • 10.1. Global Personalized Medicine Market: Regional overview
    • 10.1.1. Global Personalized medicine Market revenue share, by region, 2024 and 2032
  • 10.2. North America
    • 10.2.1. North America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million)
    • 10.2.2. North America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
    • 10.2.3. North America Personalized medicine market revenue, by Application, 2024 - 2032 (USD Million)
    • 10.2.4. The U.S.
      • 10.2.4.1. The U.S. Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million)
      • 10.2.4.2. The U.S. Personalized medicine market revenue, by Application, 2024 - 2032 (USD Million)
      • 10.2.4.3. The U.S. Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.2.4.4. The U.S. Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
    • 10.2.5. Rest of North America
      • 10.2.5.1. Rest of North America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
      • 10.2.5.2. Rest of North America Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.2.5.3. Rest of North America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.2.5.4. Rest of North America Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
  • 10.3. Europe
    • 10.3.1. Europe Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
    • 10.3.2. Europe Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
    • 10.3.3. Europe Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million)
    • 10.3.4. Europe Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
    • 10.3.5. Germany
      • 10.3.5.1. Germany Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
      • 10.3.5.2. Germany Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.3.5.3. Germany Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million)
      • 10.3.5.4. Germany Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
    • 10.3.6. France
      • 10.3.6.1. France Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
      • 10.3.6.2. France Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.3.6.3. France Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.3.6.4. France Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
    • 10.3.7. UK
      • 10.3.7.1. UK Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
      • 10.3.7.2. UK Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.3.7.3. UK Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.3.7.4. UK Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
    • 10.3.8. Rest of Europe
      • 10.3.8.1. Rest of Europe Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
      • 10.3.8.2. Rest of Europe Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.3.8.3. Rest of Europe Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.3.8.4. Rest of Europe Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
  • 10.4. Asia Pacific
    • 10.4.1. Asia Pacific Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032, (USD Million)
    • 10.4.2. Asia Pacific Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
    • 10.4.3. Asia Pacific Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
    • 10.4.4. Asia Pacific Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
    • 10.4.5. China
      • 10.4.5.1. China Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million)
      • 10.4.5.2. China Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.4.5.3. China Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.4.5.4. China Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
    • 10.4.6. Japan
      • 10.4.6.1. Japan Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
      • 10.4.6.2. Japan Personalized medicine market revenue, by Application, 2024 - 2032 (USD Million)
      • 10.4.6.3. Japan Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.4.6.4. Japan Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
    • 10.4.7. India
      • 10.4.7.1. India Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
      • 10.4.7.2. India Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.4.7.3. India Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.4.7.4. India Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
    • 10.4.8. Rest of Asia Pacific
      • 10.4.8.1. Rest of Asia Pacific Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
      • 10.4.8.2. Rest of Asia Pacific Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.4.8.3. Rest of Asia Pacific Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.4.8.4. Rest of Asia Pacific Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
  • 10.5. Latin America
    • 10.5.1. Latin America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032, (USD Million)
    • 10.5.2. Latin America Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
    • 10.5.3. Latin America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
    • 10.5.4. Latin America Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
    • 10.5.5. Brazil
      • 10.5.5.1. Brazil Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
      • 10.5.5.2. Brazil Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.5.5.3. Brazil Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.5.5.4. Brazil Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
    • 10.5.6. Rest of Latin America
      • 10.5.6.1. Rest of Latin America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
      • 10.5.6.2. Rest of Latin America Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.5.6.3. Rest of Latin America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.5.6.4. Rest of Latin America Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
  • 10.6. The Middle East and Africa
    • 10.6.1. The Middle East and Africa Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032, (USD Million)
    • 10.6.2. The Middle East and Africa Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
    • 10.6.3. The Middle East and Africa Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
    • 10.6.4. The Middle East and Africa Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
•  
• Chapter 11. Company Profile
  • 11.1. F. Hoffmann-La Roche Ltd.
    • 11.1.1. Overview
    • 11.1.2. Financials
    • 11.1.3. Therapeutic Area portfolio
    • 11.1.4. Business strategy
    • 11.1.5. Recent developments
  • 11.2. Pfizer Inc.
    • 11.2.1. Overview
    • 11.2.2. Financials
    • 11.2.3. Therapeutic Area portfolio
    • 11.2.4. Business strategy
    • 11.2.5. Recent developments
  • 11.3. Qiagen
    • 11.3.1. Overview
    • 11.3.2. Financials
    • 11.3.3. Therapeutic Area portfolio
    • 11.3.4. Business strategy
    • 11.3.5. Recent developments
  • 11.4. AstraZeneca Plc.
    • 11.4.1. Overview
    • 11.4.2. Financials
    • 11.4.3. Therapeutic Area portfolio
    • 11.4.4. Business strategy
    • 11.4.5. Recent developments
  • 11.5. Merck & Co., Inc.
    • 11.5.1. Overview
    • 11.5.2. Financials
    • 11.5.3. Therapeutic Area portfolio
    • 11.5.4. Business strategy
    • 11.5.5. Recent developments
  • 11.6. Siemens Healthcare GmbH
    • 11.6.1. Overview
    • 11.6.2. Financials
    • 11.6.3. Therapeutic Area portfolio
    • 11.6.4. Business strategy
    • 11.6.5. Recent developments
  • 11.7. Vertex Pharmaceuticals Incorporated
    • 11.7.1. Overview
    • 11.7.2. Financials
    • 11.7.3. Therapeutic Area portfolio
    • 11.7.4. Business strategy
    • 11.7.5. Recent developments
  • 11.8. Becton, Dickinson and Company
    • 11.8.1. Overview
    • 11.8.2. Financials
    • 11.8.3. Therapeutic Area portfolio
    • 11.8.4. Business strategy
    • 11.8.5. Recent developments

Table Of Figures

List of Figures 

1. Market research process
2. Market research methodology
3. Global Personalized medicine market revenue, 2024 - 2032 (USD Million) 
4. Porter’s Five Forces Analysis
5. Personalized medicine market attractiveness analysis, by Therapeutic Area segment
6. Personalized Medicine Market: Market attractiveness analysis, by Application Segment
7. Personalized medicine market: Market attractiveness analysis, by Technology segment
8. Personalized medicine market: Market attractiveness analysis, by End-User segment
9. Personalized Medicine Market: Market attractiveness analysis, by Regional segment
10. Company market share analysis, 2024
11. Global Personalized medicine market revenue share by Therapeutic Area, 2024 and 2032
12. Global Oncology market, 2024 - 2032 (USD Million)
13. Global Neurology market, 2024 - 2032 (USD Million)
14. Global Cardiology market, 2024 - 2032 (USD Million)
15. Global Antiviral market, 2024 - 2032 (USD Million)
16. Global Psychiatry market, 2024 - 2032 (USD Million)
17. Global Others Market, 2024 - 2032 (USD Million)
18. Global Competitive Personalized medicine, 2024 - 2032 (USD Million)
19. Global Personalized medicine market revenue share by Application, 2024 and 2032
20. Global Companion diagnostics market, 2024 - 2032 (USD Million) 
21. Global Health informatics market, 2024 - 2032 (USD Million) 
22. Global Health informatics market, 2024 - 2032 (USD Million)
23. Global Clinical research market, 2024 - 2032 (USD Million)
24. Global Personalized medicine market revenue share by Technology, 2024 and 2032
25. Global Pharmacogenomics market, 2024 - 2032 (USD Million)
26. Global Metabolomics market, 2024 - 2032 (USD Million)
27. Global Pharmacoproteomics market, 2024 - 2032 (USD Million)
28. Global Pharmacogenetics market, 2024 - 2032 (USD Million)
29. Global Stem cell therapy market, 2024 - 2032 (USD Million)
30. Global Pharmacodynamics market, 2024 - 2032 (USD Million)
31. Global Point of care market, 2024 - 2032 (USD Million)
32. Global Pharmacokinetics market, 2024 - 2032 (USD Million)
33. Global Personalized medicine market revenue share by End-User, 2024 and 2032
34. Global Hospitals market, 2024 - 2032 (USD Million)
35. Global Molecular diagnostic laboratories and testing facilities market, 2024 – 2032 (USD Million)
36. Global Academic institutes, Clinical care and research laboratories market, 2024 – 2032 (USD Million)
37. Global Contract research organization market, 2024 – 2032 (USD Million)
38. Global Bio and health informatics companies market, 2024 – 2032 (USD Million)
39. Global Others market, 2024 – 2032 (USD Million)

Table Of Tables

List of Tables

1.    Personalized medicine: Market Snapshot
2.    Drivers of global Personalized medicine market: Impact analysis 
3.    Restraints of global Personalized medicine market: Impact analysis 
4.    North America Personalized medicine market revenue, by Therapeutic Area, 2024 – 2032 (USD Million) 
5.    North America Personalized medicine revenue, by Application, 2024 - 2032 (USD Million) 
6.    North America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
7.    North America Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million)
8.    The U.S. Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
9.    The U.S. Personalized medicine revenue, by Application, 2024 - 2032 (USD Million) 
10.    The U.S. Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
11.    The U.S. Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million)
12. Rest of North America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
13.    Rest of North America Personalized medicine revenue, by Application, 2024 - 2032 (USD Million) 
14.    Rest of North America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
15.    Rest of North America Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million)
16.    Europe personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million)
17. Europe Personalized medicine revenue, by Application, 2024 - 2032 (USD Million)
18.    Europe Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
19.    Europe Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
20.    U.K. personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million)
21.    U.K. Personalized medicine revenue, by Application, 2024 - 2032 (USD Million)
22.    U.K. Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
23.    U.K. Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
24.    Germany personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million)
25.    Germany Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
26.    Germany Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
27.    Germany Personalized medicine market revenue, by End-User type, 2024 - 2032(USD Million) 
28. France personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
29. France Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
30.    France Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million) 
31.    France Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
32.    Rest of Europe Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million) 
33.    Rest of Europe Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
34.    Rest of Europe Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million) 
35.    Rest of Europe Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
36.    Asia Pacific Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million) 
37.    Asia Pacific Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
38.    Asia Pacific Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
39.    Asia Pacific Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
40.    China Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
41.    China Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
42.    China Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million) 
43.    China Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
44.    Japan Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million) 
45.    Japan Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
46.    Japan Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
47.    Japan Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
48.    India Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
49.    India Personalized medicine revenue, by Application, 2024 – 2032 (USD Million)
50.    India Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million) 
51.    India Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
52. Rest of Asia Pacific Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
53.    Rest of Asia Pacific Personalized medicine revenue, by Application, 2024 - 2032 (USD Million) 
54.    Rest of Asia Pacific Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
55.    Rest of Asia Pacific Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
56. Latin America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
57.    Latin America Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
58.    Latin America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
59.    Latin America Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
60. Brazil Personalized medicine market revenue, by Therapeutic Area, 2024 – 2032 (USD Million) 
61.    Brazil Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
62.    Brazil Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million) 
63.    Brazil Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
64. Rest of Latin America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
65.    Rest of Latin America Personalized medicine revenue, by Application, 2024 - 2032 (USD Million) 
66.    Rest of Latin America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
67.    Rest of Latin America Personalized medicine market revenue, by End-User type, 2024 - 2032(USD Million) 
68. The Middle East and Africa Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
69.    The Middle East and Africa Personalized medicine revenue, by Application, 2024 – 2032 (USD Million) 
70.    The Middle East and Africa Personalized medicine market revenue, by Technology, 2024 – 2032 (USD Million) 
71.    The Middle East and Africa Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million)